Most Recent Additions*
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer.
Frank A Sinicrope, Fang-Shu Ou, Dirk Arnold, Walter R Peters, Robert J Behrens, Christopher H Lieu, Khalid Matin, Deirdre J Cohen, Samara L Potter, Andrew B Nixon, Lisa A Kottschade, Emily Kathol, Wendy L Frankel, Ardaman Shergill, Dennis Hsu, Anke Reinacher-Schick, Paul Mehan, Philip J Gold, Maged F Khalil, Tyler Zemla, Clare Gatten, Eileen M O'Reilly, and Jeffrey A Meyerhardt
Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From the Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept AFFINITY Study.
Jose U Scher, Iain B McInnes, Enrique R Soriano, Joseph F Merola, Paul Bird, Vinod Chandran, Edaire Cheng, Elena Reynoso, Warner Chen, Maoji Li, Lianne S Gensler, Philip J Mease, and Christopher T Ritchlin
Comparative physiological and genomic characterization of a novel
Zachary Flinkstrom, Kristopher A Hunt, Britt Abrahamson, Pierce Harvell, Xiangpeng Li, James Wilson, Zachary S Cooper, Jacob J Valenzuela, Nitin S Baliga, David A Stahl, Wei Qin, and Mari-Karoliina H Winkler
Direct-to-Participant Enrollment in a Virtual Trial: Lessons Learned From the Heartline Study.
Mellanie True Hills, Serge Korjian, Gerald Chi, Andrea Natale, Leslie Saxon, Keith C Ferdinand, Kevin F Kwaku, Scott Brancato, Amy Hughes, Katie Baca-Motes, Steven R Steinhubl, Jeffrey Wessler, Nieca Goldberg, Anisha Asthana, Kate Shute, Jill Applebaum, Kathleen Doran, Janeta Nikolovski, Simrati Kaul, Dereck Wentworth, C V Damaraju, Cammie Tavakoli, Mithun Patel, Anne B Curtis, John A Spertus, C Michael Gibson, and Heartline Executive Committee and Steering Committee
Diminishing returns of disease-modifying treatment in older participants of multiple sclerosis clinical trials.
Eva Strijbis, Jop Mostert, Miguel D'Haeseleer, Ester Moral, Luis Brieva Ruiz, Jacynthe Comtois, Joep Killestein, Pavle Repovic, Tarrant McPherson, Gary Cutter, and Marcus Koch
Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS Study.
Murat Torgutalp, Raquel Almodovar, Valderilio F Azevedo, Xenofon Baraliakos, Filip Van den Bosch, Jürgen Braun, Vinod Chandran, Laura C Coates, Atul Deodhar, Torsten Diekhoff, Filippo Fagni, Alberto Floris, Floris A van Gaalen, Rodrigo Garcia-Salinas, Lianne S Gensler, Niti Goel, Alice B Gottlieb, Désirée van der Heijde, Philip S Helliwell, Kay Geert A Hermann, Umut Kalyoncu, Uta Kiltz, Francis Kynaston-Pearson, Robert Gw Lambert, Ramasharan Laxminarayan, Ying Ying Leung, Maria Llop, Clementina López-Medina, Alejandra López-Rodríguez, Michele M Luchetti Gentiloni, Miranda van Lunteren, Marina Magrey, Ajesh B Maharaj, Hernán Maldonado-Ficco, Walter P Maksymowych, Helena Marzo-Ortega, Marco Massarotti, Ashish J Mathew, Philip Mease, Peter Nash, Victoria Navarro-Compán, Mikkel Østergaard, Fabian Proft, Mikhail Protopopov, Roberto Ranza, Sherry Rohekar, Carlo Salvarani, Ruxandra E Schiotis, Nicholas Shenker, Joachim Sieper, Dilek Solmaz, Enrique R Soriano, Lai- Shan Tam, Ricardo Acayaba de Toledo, James Cc Wei, Nelly Ziade, Dafna D Gladman, and Denis Poddubnyy
Myofibroblast programming blocks differentiation of TLS-organizing fibroblastic reticular cells in pancreatic cancer.
Elijah Kirschstein, Olivia Harder, Jordan Krull, Madison Sikorski, Shrijan Khanal, Morgan Mack, Carl F Ware, Elizabeth Evans, Michael J Gough, Qin Ma, Wei Chen, Kristina H Young, and Andrew J Gunderson
Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced
Benjamin Besse, Vivek Subbiah, Giuseppe Curigliano, Daniel W Bowles, Robert C Doebele, Aaron S Mansfield, Christina S Baik, Gilberto de Lima Lopes, Luis Paz-Ares, Matthew H Taylor, Daniel S W Tan, Guzman Alonso, Shirish M Gadgeel, Gregory P Kalemkerian, Sai-Hong Ignatius Ou, Anthonie J van der Wekken, Carlos R Becerra, Makenzi Evangelist, Frank Griesinger, Stephen V Liu, Yanyan Lou, Julien Mazières, Jason M Melear, Mohit Narang, Ashish Saxena, Michael Thomas, Sophia Wang, Amber Thomassen, Dae Ho Lee, Dong-Wan Kim, and Justin F Gainor
CD8 PET imaging with [89Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study
Michael A Postow, Peter D Zang, Sumanta K Pal, Audrey Mauguen, Michael Farwell, Michael Gordon, David Hays, Jeffrey Y C Wong, Delphine Chen, Gary A Ulaner, Giuseppe Esposito, Jonathan McConathy, Michael M Graham, Anthony F Shields, Annick D Van den Abbeele, Marcus O Butler, Jacob S Thomas, Przemyslaw Twardowski, Jayant Narang, Aman P Singh, Agnish Dey, Kevin P Maresca, Edmund Keliher, Feng Liu, Guillaume Potdevin, Guenter Schmidt, William Le, Ian Wilson, Alessandro Mascioni, Fang Jia, Ronald Korn, Michael R Ferris, Kristin Schmiedehausen, Neeta Pandit-Taskar, and Kim A Margolin
Metabolomic signatures of extreme old age: findings from the New England Centenarian Study.
Stefano Monti, Michael S Lustgarten, Ziwei Huang, Zeyuan Song, Mengze Li, Dylan Ellis, Qu Tian, Luigi Ferrucci, Noa Rappaport, Stacy L Andersen, Thomas P Perls, and Paola Sebastiani
DIVA Difficult Intravenous Access Assessment
Aileen M. Romero and Mary Jo Sarver
Composite Metrics to Assess Quality Improvement in Very Low Birth Weight Infants: 2010-2023.
Joseph Kaempf, Shih Ting Chiu, Erika M Edwards, and Roger F Soll
KGBN: Augmenting and optimizing logical gene regulatory networks using knowledge graphs.
Luna Xingyu Li, Yue Zhang, Boris Aguilar, Tazein Shah, John H Gennari, and Guangrong Qin
Response to publication: Percutaneous micro-axial flow pump use during non-emergent high-risk PCI: Systematic review and meta-analysis by Elbenawi et al.
Jason R Wollmuth, Cristina Aurigemma, Vasileios F Panoulas, and Amir Kaki
Community benchmarking and evaluation of human unannotated microprotein detection by mass spectrometry based proteomics.
Aaron Wacholder, Eric W Deutsch, Leron W Kok, Jip T van Dinter, Jiwon Lee, James C Wright, Sebastien Leblanc, Ayodya H Jayatissa, Kevin Jiang, Ihor Arefiev, Kevin Cao, Francis Bourassa, Felix-Antoine Trifiro, Michal Bassani-Sternberg, Pavel V Baranov, Annelies Bogaert, Sonia Chothani, Ivo Fierro-Monti, Daria Fijalkowska, Kris Gevaert, Norbert Hubner, Jonathan M Mudge, Jorge Ruiz-Orera, Jana Schulz, Juan Antonio Vizcaíno, John R Prensner, Marie A Brunet, Thomas F Martinez, Sarah A Slavoff, Xavier Roucou, Jyoti S Choudhary, Sebastiaan van Heesch, Robert L Moritz, and Anne-Ruxandra Carvunis
Polyethylene hip resurfacing in patients with lower leg amputations.
James W. Pritchett
Ultra-deep duplex sequencing reveals unique features of somatic evolution in the normal tissues of a family with Li-Fraumeni syndrome.
Hunter L Colegrove, Marianne E Dubard-Gault, Henry Marshall, Brendan F Kohrn, Thomas H Smith, Zachary K Norgaard, Fang Yin Lo, Elizabeth K Schmidt, Jacob E Higgins, Charles C Valentine, Desiree A Marshall, John I Clark, Eric Q Konnick, Jesse J Salk, Marshall S Horwitz, Raheleh Rahbari, Alison F Feder, and Rosa Ana Risques
Wildfire disruptions and cancer care: A multi-institutional study of radiotherapy treatment adherence in Northern California.
R A Sabol, C J Walsh, S Densley, Y Medhat, C C Baniel, A Krishna, C T Baiyee, D Meltzer, J Boscardin, A Witztum, N Pitts, A K Paulsson, Join Y Luh, L Zalavari, S S Yom, and K Lichter
Results of a phase II trial of short-course radiation and TASOX [trifluridine/tipiracil (TAS-102) plus oxaliplatin] chemotherapy in operable rectal cancer.
H F Kennecke, J A Zell, H Pham, V V Simianu, K Herz, A Kelley, J C Carmichael, H Hochster, and L A Kachnic
Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial.
James M Foran, Zhuoxin Sun, Selina M Luger, David F Claxton, Hillard M Lazarus, Daniel A Arber, Jacob M Rowe, Elisabeth Paietta, Janis Racevskis, Fran Garrett-Bakelman, Yanming Zhang, Jessica K Altman, Aref Al-Kali, Hong Zheng, Keith W Pratz, E Randolph Broun, Bayard L Powell, Kristen Marie O'Dwyer, John E Godwin, Yishai Ofran, Mark R Litzow, and Martin S Tallman
*Updated as of 04/27/26.
